NCT01997580

Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder

Phase 4 Study of Escitalopram Treatment and Biomarkers in Major Depressive Disorder

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 600 (estimated)
• Sponsor: Seoul National University Bundang Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Accepted

Summary

To explore electrophysiologic parameters and biomarkers predicting treatment response of patients with major depressive disorder To explore electrophysiologic parameters and biomarkers predicting suicide risk of patients with major depressive disorder

Detailed description

Case-control study Repeated measures design

Conditions

• Major Depressive Disorder

Interventions

Type	Name	Description
DRUG	escitalopram	SSRI antidepressant

Timeline

• Start date: 2013-07-01
• Primary completion: 2016-12-01
• Completion: 2018-12-01
• First posted: 2013-11-28
• Last updated: 2013-11-28

Locations

1 site across 1 country: South Korea